Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMBINATION DRUG SUITABLE FOR TREATMENT AND PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLAD) AND/OR NON-ALCOHOLIC STEATOHEPATITIS (NASH), AND/OR HEPATIC STEATOSIS
Document Type and Number:
WIPO Patent Application WO/2019/106851
Kind Code:
A1
Abstract:
[Problem] To provide a pharmaceutical product and health food that are suitable for treatment and prevention of hepatitis virus-unrelated non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic steatosis. [Solution] This combination drug contains a zinc preparation and a selenium preparation as active ingredients, and is suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic steatosis.

Inventors:
KUBOTA, Satoru (A2-412, 1-22 Yamadanishi, Suita-sh, Osaka 24, 〒5650824, JP)
KONO, Toru (1-6-22, 2-jo Toyooka, Asahikawa-sh, Hokkaido 32, 〒0788232, JP)
Application Number:
JP2017/043898
Publication Date:
June 06, 2019
Filing Date:
November 30, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDICO CONSL CO., LTD. (A2-412, 1-22 Yamadanishi, Suita-sh, Osaka 24, 〒5650824, JP)
International Classes:
A61K33/30; A23L33/16; A61K33/04; A61P1/16
Domestic Patent References:
WO2016139740A12016-09-09
Foreign References:
JP4802470B22011-10-26
JPS5337245B21978-10-07
JPH035367B21991-01-25
Other References:
ZHANG, GE-HONG ET AL.: "Influence of sodium selenite on antioxidant function of rat liver with NASH", CHINESE REMEDIES & CLINICS, vol. 9, no. 8, August 2009 (2009-08-01), pages 707 - 708
SINGAL, ASHWANI K. ET AL.: "Antioxidants as therapeutic agents for liver disease", LIVER INTERNATIONAL, vol. 31, no. 10, November 2011 (2011-11-01), pages 1432 - 1448, XP055615661, ISSN: 1478-3223
YANG, ZE-RAN ET AL.: "Salidroside alleviates oxidative stress in the liver with non-alcoholic steatohepatitis in rats", BMC PHARMACOLOGY AND TOXICOLOGY, vol. 17, no. 16, 14 April 2016 (2016-04-14), XP055615662
ONO MASAFUMI ET AL.: "Approches to Diagnosis : Points for Introductions to Specialists", THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, vol. 105, no. 1, 10 January 2016 (2016-01-10), pages 47 - 55, XP055628774, DOI: 10.2169/naika.105.47
KUMAGAI NAOKI ET AL.: "Discussion of Zinc Hepatic Fibrosis Effects in Mouse NASH Models", KANZO, vol. 48, no. Supplement 2, 15 September 2007 (2007-09-15), pages A447, ISSN: 0451-4203
TANAKA HIROAKI ET AL.: "Effects of Branched-Chain Amino Acids and Antioxidant Micronutrients on Non-Alcoholic Steatohepatitis (NASH)", THE JAPANESE JOURNAL OF SURGICAL METBOLISM AND NUTRITION- 48TH ANNUAL MEETING OF JAPANSES SOCIETY FOR SURGICAL METABOLISM AND NUTRITION : PROGRAM AND PROCEEDINGS, vol. 45, no. 3, June 2011 (2011-06-01), pages 113
LI, TAN ET AL.: "Vitamin E and Se interfere in cytochrome P 4501A1 and lipid peroxidation in nonalcoholic fatty liver diseases in rats", WORLD CHINESE JOURNAL OF DIGESTOLOGY, vol. 15, no. 28, 8 October 2007 (2007-10-08), pages 2977 - 2982, XP009516564, ISSN: 1009-3079
ADAMS LA: "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", J. HEPATOLOGY, vol. 42, no. 1, 2005, pages 132 - 138, XP025293900, doi:10.1016/j.jhep.2004.09.012
ADAMS LA: "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", GASTROENTEROLOGY, vol. 129, no. 1, 2005, pages 113 - 121, XP005313832, doi:10.1053/j.gastro.2005.04.014
MING DING: "Selenium Supplementation Decreases Hepatic Fibrosis in Mice After Chronic Carbon Tetrachloride Administration", BIOL TRACE ELEM RES, vol. 133, no. 1, 2010, pages 83 - 97
KLEINER. D. E: "Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease", HEPATOLOGY, vol. 41, no. 6, 2005, pages 1313 - 1321, XP055123202, doi:10.1002/hep.20701
SUGINO.H: "Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis", J GASTROENTEROL HEPATOL, vol. 23, no. 12, 2008, pages 1909 - 1916
TAKAMATSU SEIGO: "Beneficial effects of zinc supplement in NAFLD treatment", THERAPUTIC RESEARCH, vol. 32, no. 7, 2011, pages 967 - 973
Y MURATA: "Nonalcoholic steatohepatitis (NASH) after pancreatico-duodenectomy: association of pancreatic exocrine deficiency and infection", CLIN J GASTROENTEROL, April 2011 (2011-04-01), pages 242 - 248
MICHIKO ITOH: "Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans", PLOS ONE, vol. 8, no. 12, 2013, pages e82163
KRIS V KOWDLEY: "Elevated serum ferritin is an independent predictor of histologic severity and advanced fibrosis among patients with nonalcoholic fatty liver disease", HEPATOLOGY, vol. 55, no. 1, 2012, pages 77 - 85
KOUICHI MIURA: "Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2", AM J PHYSIOL GASTROINTEST LIVER PHYSIOL, vol. 302, 2012, pages 1310 - 1321
CHRISTI A MATTEONI: "Nonalcoholic Fatty Liver Disease: A Spectrum of Clinical and Pathological Severity", GASTROENTEROLOGY, vol. 116, 1999, pages 1413 - 1419
Attorney, Agent or Firm:
MIYAZAKI, Tadaaki et al. (MIYAZAKI INTERNATIONAL PATENT ATTORNEYS, Live Building 203 30-13, Tarumi-cho 3-chome, Suita-sh, Osaka 62, 〒5640062, JP)
Download PDF: